Wide release: Available for free by July 15, 2026, on Apple, Spotify, YouTube, etc.
Not medical advice.
Nick speaks with Dr. William Banks about the blood-brain barrier. Banks, who has spent over 45 years studying it, shows that the barrier is a sophisticated, regulated interface that permits bidirectional communication between body and brain. Key concepts include how small lipid-soluble molecules and specific peptide transporters enable entry of signaling molecules, the role of efflux systems, and how barrier changes contribute to aging and neurodegenerative disease. They also discuss practical implications for peptide-based therapeutics and drug delivery to the central nervous system.
TOPICS DISCUSSED:
Blood-Brain Barrier Structure: Capillary endothelial cells with tight junctions, absent fenestrae, and minimal vesicles create a selective interface; supported by astrocytes and pericytes.
Crossing Mechanisms: Lipid-soluble small molecules diffuse passively; glucose, amino acids, and regulatory peptides use saturable transporters whose rates vary by need.
Peptide Transport: Many peptides cross via lipid solubility or specific transporters; rate, not all-or-none presence, determines biological relevance; efflux systems remove some (e.g. certain enkephalins).
Dynamic Regulation: Transporters for leptin and insulin are modulated by epinephrine, triglycerides, and brain demand; changes occur in aging and Alzheimer’s (reduced glucose uptake, impaired Aβ efflux).
Circumventricular Organs: Leaky capillary regions allow rapid sampling of blood signals while tanycytes limit spread to surrounding brain tissue.
Drug Delivery Challenges: Small lipid-soluble drugs, barrier disruption (e.g. focused ultrasound), and “Trojan-horse” strategies each have limitations; intranasal delivery shows rapid brain distribution.
Peptides & Brain Effects: Gut peptides like GLP-1 analogs, insulin, and ghrelin influence cognition and memory; brain entry predicts central effects.
ABOUT THE GUEST: William Banks, MD is a physician-scientist and leading researcher on the blood-brain barrier. He has focused on humoral brain-body communication, peptide transport, and the barrier’s role in health and disease.
RELATED CONTENT:
M&M 298 | GLP-1s & Novel Peptides in Obesity, Diabetes & Metabolic Health | Katrin Svensson
KNOW YOURSELF:
Visit the SUPPORT PAGE if you find value in this content. Includes discount codes + links to affiliate partners, including products to help you measure and manage your health.
Listen or watch on your favorite platform:
PRACTICAL TAKEAWAYS:
The brain receives many gut and fat-derived signals (leptin, GLP-1) that affect appetite, metabolism, and cognition—supporting metabolic health benefits brain function.
Most small lipid-soluble molecules reach the brain; highly polar or large peptides usually require specific design or delivery methods.
Aging and inflammation subtly alter barrier function; prioritize sleep, exercise, and metabolic health to support vascular integrity.
When evaluating peptide supplements or drugs, consider whether they are formulated to cross or act at the barrier; brain effects depend on transport.
SUBSCRIBER CONTENT BELOW: Reference paper + episode transcript.
